NEWS: Ketchum races Janssen rivals with Risperdal

Ketchum London has clinched an estimated pounds 1.25 million-fee contract to manage global public relations for Janssen Pharmaceutica’s schizophrenia drug Risperdal.

Ketchum London has clinched an estimated pounds 1.25 million-fee

contract to manage global public relations for Janssen Pharmaceutica’s

schizophrenia drug Risperdal.



The Brussels-based company is believed to be allocating a total budget

in excess of pounds 2 million for Risperdal in order to combat the

imminent launch of schizophrenia treatments from rivals Eli Lilly and

Zeneca.



Four directors, including Ketchum’s head of healthcare Paul Blackburn,

an account manager and executive will execute the campaign for

Risperdal, a seratonin and dopa-mine antagonist (SDA).



The team is preparing for its first major event, the World Psychiatric

Association Con-gress, which will be held in Madrid later this month.



Blackburn was cagey about campaign details but said health

professionals, carers and patients will be targeted in the campaign via

trade and consumer media and third party organisations.



Launched in 1993, Risper-dal treats both positive symptoms - delusions

and hallucinations - and negative symptoms such as social withdrawal,

mood change and loss of drive.



According to the mental health charity SANE, one in a hundred people

suffer from schizophrenia symptoms.



Blackburn added that he hoped the new 18-month contract, plus its

appointment to work on Organon’s anti-depressant Remeron last May, would

lift Ketchum into the top 10 healthcare agencies.



Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Max Clifford trial jury to reconvene tomorrow after majority verdicts direction

Max Clifford trial jury to reconvene tomorrow after majority verdicts direction

The jury in the trial of celebrity publicist Max Clifford on 11 charges of indecent assault has been sent home for the day after being told by the judge earlier this afternoon that he will now accept majority verdicts.

Labour "fooling themselves" over plans to combat attacks on Miliband

Labour "fooling themselves" over plans to combat attacks on Miliband

Conservative-leaning public affairs experts have questioned the value of Labour's adoption of US-style campaigning tactics in the wake of the opposition hiring election strategist David Axelrod.

PLMR appoints Professor Tim Morris as non-executive director

The vet who helped establish the British Horseracing Authority's anti-doping and animal welfare programme has joined PLMR as a non-executive director.